Media

Keep up to date with all the latest news and updates from Virax Biolabs.

 

Virax Biolabs Believes Technology Aligns with Unites States Department of Health and Human Services’ Transparency Priority on Vaccine Efficacy

Read more

“What Does 2025 Hold For Biopharma? Part 6: Therapeutic Area Advances”: Industry leaders including Virax CEO, James Foster, share their expectations for the year ahead

Read more

“Global Launch Strategies in the Current Political Climate”: Virax CEO, James Foster, discusses how global launches are being impacted by changing geopolitical conditions

Read more

“Lyme Disease: Are we Close to an Effective Diagnostic Test?”: Dr. Nigel McCracken speaks to Clinical Lab Products Magazine

Read more

“Combating chronic inflammation through immune diagnostics”: Dr. Nigel McCracken speaks to Longevity.Technology

Read more

Virax Biolabs’ CEO James Foster Issues Letter to Shareholders

Read more

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland

Read more

Virax Biolabs: Interview With COO Nigel McCracken About The Diagnostics And Detection Company

Read more

A Diagnosis in Demand – The Urgent Need for Post-Acute Infection Syndrome (PAIS) Testing by Dr. Elihu Aranday-Cortes

Read more

Discovering Solutions for Long COVID: A T Cell Immunology Breakthrough (feat. Dr. Nigel McCracken)

Read more

Detecting T Cell Dysfunction in Post-Acute Infection Syndromes (feat. Dr. Nigel McCracken)

Read more

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland

Read more